Back
Universal Insurance Holdings 10K Form
Sell
35
UVE
Universal Insurance Holdings
Last Price:
$21.86
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-30 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2023-10-30 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2023-07-31 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2023-05-02 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2023-02-17 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2022-11-02 | 10Q | UVE/Universal Insurance Holdings Quarterly |
Receive UVE News And Ratings
See the #1 stock for the next 7 days that we like better than UVE
UVE Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5B |
|---|---|
| Cash Flow: | $-102.2M |
| Price / Cash Flow: | 4.87 |
| Annual Sales: | $13.28 |
| Price / Book: | 1.64 |
Profitability
| EPS (TTM): | 1.99000 |
|---|---|
| Net Income (TTM): | $58.9M |
| Gross Margin: | -- |
| Return on Equity: | 15.73% |
| Return on Assets: | 2.34% |
Universal Insurance Holdings Earnings Forecast
Key Universal Insurance Holdings Financial Ratios
-
The Interest Expense is 9.79% of Operating Income.
-
The Net Earning history of UVE is 3.88% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 15 years.
Universal Insurance Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | UVE |
| CUSIP: | 91359V |
| Website: | universalinsuranceholdings.com |
Debt
| Debt-to-Equity Ratio: | 0.27 |
|---|---|
| Current Ratio: | 5.49 |
| Quick Ratio: | 4.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.85 |
|---|---|
| Forward P/E Ratio: | 7.65 |
UVE Technical Analysis vs Fundamental Analysis
Sell
35
Universal Insurance Holdings (UVE)
is a Sell
Is Universal Insurance Holdings a Buy or a Sell?
-
Universal Insurance Holdings stock is rated a SellThe current Universal Insurance Holdings [UVE] share price is $21.87. The Score for UVE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.